Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (r*,s*)-4,4'-(2,3-dimethylbutane-1,4-diyl)bispyrocatechol
2. Acid, Meso-nordihydroguaiaretic
3. Actinex
4. Dihydronorguaiaretic Acid
5. Masoprocol
6. Meso Nordihydroguaiaretic Acid
7. Meso-nordihydroguaiaretic Acid
8. Nordihydroguaiaretic Acid, (r*,s*)-isomer
1. 500-38-9
2. Ndga
3. Dihydronorguaiaretic Acid
4. Actinex
5. 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
6. Nordihydroguairaretic Acid
7. Norhydroguaiaretic Acid
8. Norguaiaretic Acid, Dihydro-
9. 1,2-benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-
10. Dinorguaiaretic Acid, Dihydro-
11. 4,4'-(2,3-dimethyltetramethylene)dipyrocatechol
12. Nsc 4291
13. 2,3-bis(3,4-dihydroxyphenylmethyl)butane
14. Nordihydroguaretic Acid
15. Pyrocatechol, 4,4'-(2,3-dimethyltetramethylene)di-
16. 4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)
17. Chembl52
18. Nordihydroguaiaretic Acid (unspecified)
19. Butane, 1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethyl-
20. Mls000069451
21. Chebi:7625
22. Beta,gamma-dimethyl-alpha,delta-bis(3,4-dihydroxyphenyl)butane
23. Nsc4291
24. Chx 100; Masoprocol; Meso-ndga
25. Nordihydroguaiaretate
26. 1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane
27. Nsc682984
28. 4,4'-(2,3-dimethylbutane-1,4-diyl)dibenzene-1,2-diol
29. 4,4'-(2,3-dimethylbutane-1,4-diyl)bis(benzene-1,2-diol)
30. Smr000059049
31. Nordihydroguaiaretic Acid (ndga)
32. Nordihydroguiaretic Acid
33. Ccris 1399
34. Einecs 207-903-0
35. Norguaiaretic Acid, Dihydro
36. Nsc 682984
37. Ai3-23059
38. Ndga;masoprocol
39. Ncgc00015741-06
40. 2,3-dimethyl-1,4-bis(3,4-dihydroxyphenyl)butane
41. Mfcd00002206
42. Lox Inhibitor, N/a
43. Spectrum_001146
44. 4,4'-(2,3-dimethyl-1,4-butanediyl)bis(1,2-benzenediol)
45. Nordihydroguajaretic Acid
46. Spectrum5_000735
47. Dsstox_cid_2437
48. Cid_4534
49. Dsstox_rid_76590
50. Dsstox_gsid_22437
51. Oprea1_368609
52. Kbiogr_002349
53. Kbioss_001626
54. Kbioss_002352
55. Mls002153435
56. Mls006011710
57. Divk1c_000999
58. Schembl135976
59. Gtpl4265
60. Dtxsid5022437
61. Rel-4,4'-((2r,3s)-2,3-dimethylbutane-1,4-diyl)bis(benzene-1,2-diol)
62. Bdbm32020
63. Hczkyjdfepmadg-uhfffaoysa-
64. Hms503g19
65. Kbio1_000999
66. Kbio2_001626
67. Kbio2_002349
68. Kbio2_004194
69. Kbio2_004917
70. Kbio2_006762
71. Kbio2_007485
72. Kbio3_002828
73. Nordihydro Guaiaretic Acid-[d6]
74. 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-1,2-benzenediol
75. Ndga (nordihydroguaiaretic Acid)
76. Cmap_000026
77. Ninds_000999
78. Hms2232l16
79. Hms3370g10
80. Hms3649m15
81. Bcp08590
82. Hy-n0198
83. Tox21_302171
84. 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]benzene-1,2-diol
85. S3984
86. Stl570288
87. Akos003367978
88. Ccg-207935
89. Cs-1431
90. Sdccgsbi-0050852.p002
91. Idi1_000999
92. Ndga - Cas 500-38-9
93. Smp2_000272
94. 4,3-dimethyltetramethylene)dipyrocatechol
95. Ncgc00015741-04
96. Ncgc00015741-05
97. Ncgc00015741-08
98. Ncgc00015741-09
99. Ncgc00015741-13
100. Ncgc00089785-02
101. Ncgc00089785-03
102. Ncgc00255380-01
103. Ac-24202
104. As-58406
105. Cas-500-38-9
106. Nci60_003992
107. Wln: Qr Bq D1y1&y1&1r Cq Dq
108. Xn163193
109. D0800
110. Ft-0606781
111. Nordihydroguaiaretic Acid, >=97.0% (hplc)
112. .beta.,.delta.-bis(3,4-dihydroxyphenyl)butane
113. 4,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)
114. F17140
115. N-8500
116. 1, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-
117. Pyrocatechol,4'-(2,3-dimethyltetramethylene)di-
118. 500n389
119. A913176
120. Butane,4-bis(3,4-dihydroxyphenyl)-2,3-dimethyl-
121. Sr-01000003007
122. Q7050774
123. Sr-01000003007-2
124. Pyrocatechol,4'- (2,3-diemthyltetramethylene) Di-
125. 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]pyrocatechol
126. .beta.,.gamma.-dimethyl-.alpha.,.delta.-bis(3,4-dihydroxyphenyl)butane
127. 4-[4-[3,4-bis(oxidanyl)phenyl]-2,3-dimethyl-butyl]benzene-1,2-diol
128. Nordihydroguaiaretic Acid, >=90% (hplc), From Larrea Divaricata (creosote Bush)
| Molecular Weight | 302.4 g/mol |
|---|---|
| Molecular Formula | C18H22O4 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 302.15180918 g/mol |
| Monoisotopic Mass | 302.15180918 g/mol |
| Topological Polar Surface Area | 80.9 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 303 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
44
PharmaCompass offers a list of Dihydronorguaiaretic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydronorguaiaretic Acid manufacturer or Dihydronorguaiaretic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydronorguaiaretic Acid manufacturer or Dihydronorguaiaretic Acid supplier.
PharmaCompass also assists you with knowing the Dihydronorguaiaretic Acid API Price utilized in the formulation of products. Dihydronorguaiaretic Acid API Price is not always fixed or binding as the Dihydronorguaiaretic Acid Price is obtained through a variety of data sources. The Dihydronorguaiaretic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dihydronorguaiaretic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydronorguaiaretic Acid, including repackagers and relabelers. The FDA regulates Dihydronorguaiaretic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydronorguaiaretic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dihydronorguaiaretic Acid supplier is an individual or a company that provides Dihydronorguaiaretic Acid active pharmaceutical ingredient (API) or Dihydronorguaiaretic Acid finished formulations upon request. The Dihydronorguaiaretic Acid suppliers may include Dihydronorguaiaretic Acid API manufacturers, exporters, distributors and traders.
Dihydronorguaiaretic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydronorguaiaretic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydronorguaiaretic Acid GMP manufacturer or Dihydronorguaiaretic Acid GMP API supplier for your needs.
A Dihydronorguaiaretic Acid CoA (Certificate of Analysis) is a formal document that attests to Dihydronorguaiaretic Acid's compliance with Dihydronorguaiaretic Acid specifications and serves as a tool for batch-level quality control.
Dihydronorguaiaretic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Dihydronorguaiaretic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydronorguaiaretic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydronorguaiaretic Acid EP), Dihydronorguaiaretic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydronorguaiaretic Acid USP).
